遗传性癌症检测市场基于(主要地区、市场参与者、规模和份额)- 预测至 2031 年

  • Report Code : TIPRE00006578
  • Category : Biotechnology
  • No. of Pages : 150
Buy Now

Hereditary Cancer Testing Market Growth Report 2021 to 2031

Buy Now

遗传性癌症检测市场规模预计2021年为50.5亿美元,2023年为XX亿美元,预计到2031年将达到145.9亿美元;预计 2023-2031 年复合年增长率为 11.3%。遗传性癌症患病率的增加和对遗传性癌症的认识不断提高是驱动因素。对个性化药物的偏好可能仍然是遗传性癌症检测市场趋势的关键。  

 

遗传性癌症检测市场分析

癌症是一种遗传性疾病,由控制细胞功能的基因的明确变异引起,特别是影响细胞的生长和复制。遗传性基因突变导致 5-10% 的癌症。研究人员发现了与 50 多种遗传性癌症综合征相关的特定基因突变,这些综合征影响了患有某些癌症的个体。此外,约 5-10% 的乳腺癌与从父母遗传的突变基因有关。 BRCA1 和 BRCA2 基因的变异很普遍。携带 BRCA1 突变的女性终生患乳腺癌的风险约为 72%,而携带 BRCA2 突变的女性患乳腺癌的风险约为 69%。

 

遗传性癌症检测市场概述

亚太地区是遗传性癌症检测增长最快的市场。由于韩国等国家政府对癌症认识和其他举措的支持,该地区对于遗传性癌症检测市场参与者具有巨大潜力。中国对基因测序的需求不断增长,主要是由于中国中产阶级的崛起、老年人口的增加以及医疗保健系统的不断完善。根据世界卫生组织的数据,中国政府实施了“健康中国2030”规划,这对中国人民来说是有益的。

 

定制研究以满足您的要求

我们可以优化和定制我们的标准产品无法满足的分析和范围。这种灵活性将帮助您获得业务规划和决策所需的准确信息。

遗传性癌症检测市场:

Hereditary Cancer Testing Market: Strategic Insights

Hereditary Cancer Testing Market

  • CAGR (2023 - 2031)
    11.3%
  • Market Size 2021
    US$ 5.05 Billion
  • Market Size 2031
    US$ 14.59 Billion

Key Players

  • Hologic Inc.
  • Koninklijke Philips N.V.
  • Quest Diagnostics Incorporated
  • Myriad Genetics, Inc.
  • Cancer Genetics Inc.
  • Invitae Corporation
  • Myogenes
  • Strand Life Sciences Pvt. Ltd.
  • Pathway Genomics Corporation
  • CENTOGENE AG

Regional Overview

  • 北美(美国、加拿大、墨西哥)
  • 欧洲(英国、德国、法国、俄罗斯、意大利、欧洲其他地区)
  • 亚太地区(中国、印度、日本、澳大利亚、亚太地区其他地区)
  • 南美洲和中美洲(巴西、阿根廷、南美洲和中美洲其他地区)
  • 中东和非洲(南非、沙特阿拉伯、阿联酋、中东和非洲其他地区)

Market Segmentation

诊断类型(活检、影像学)
    技术(测序、PCR、微阵列)
      最终用户(医院、诊所、诊断中心)

        遗传性癌症检测市场

        • 年均复合增长率(2023 - 2031)
          11.3%
        • 2021 年市场规模
          50.5 亿美元
        • 2031 年市场规模
          145.9 亿美元

        市场动态

        增长动力
        • 人们对遗传性癌症的认识不断增强
        未来的趋势
        • 对个性化药物的偏好
        机会
        • 多基因面板测试越来越多地采用

        关键人物;主力;重要一员

        • 豪洛捷公司
        • 皇家飞利浦公司
        • 奎斯特诊断公司
        • 无数遗传学公司
        • 癌症遗传学公司
        • 英维泰公司
        • 肌原
        • 斯特兰德生命科学列兵。有限公司
        • Pathway Genomics 公司
        • 森托金公司

        区域概况

        • 北美
        • 欧洲
        • 亚太
        • 南美洲和中美洲
        • 中东和非洲

        市场细分

        诊断类型
        • 活检
        • 影像学
        技术
        • 测序
        • 聚合酶链式反应
        • 微阵列
        最终用户
        • 医院
        • 诊所
        • 诊断中心
        • 示例 PDF 通过定性和定量分析展示了内容结构和信息的性质。

         

        遗传性癌症检测市场驱动因素和机遇

         

        人们对遗传性癌症的认识不断增强

        由于政府的各种努力,人们对遗传性癌症的认识不断提高。在过去的十年中,公共医疗、健康和科学界投入了大量资金来提高人们对遗传性癌症状况的认识,重点关注遗传性癌症风险、家族史和遗传性癌症倾向的基因检测。此外,制造商正专注于采取产品发布和批准、研发投资、政府资助和合作伙伴关系等策略,为全球患者提供便捷的服务。例如,2024 年 4 月,Ambry 启动了组织间癌症遗传学临床证据联盟 (INTERACT) 合作,以促进遗传性癌症检测,旨在增加获得专门基因检测的机会。

         

        多基因面板测试的日益采用——一个机会

        多基因面板消除了对不同癌症或变异类型进行多次测定的情况。拷贝数变异(CNV)是遗传变异的常见来源,与许多遗传性疾病有关。它也是遗传性癌症诊断的重要组成部分。

        英国政府和 Genomic England 表示,所有 CNV 分析现在都将通过 NGS 进行,而不是通过多重连接依赖性探针扩增 (MLPA) 进行。由于其优势,所有实验室流程都将得到简化,并能够使用单一工作流程和分析管道检测所有 SNV、INDEL 和 CNV 变体。

        北美、欧洲和亚洲国家将更多地采用多基因面板测试。

         

        遗传性癌症检测市场报告细分分析

        有助于遗传性癌症检测市场分析的关键部分是产品诊断类型、技术和最终用户。

        • 根据诊断类型,遗传性癌症检测市场分为活检和成像。活检细分市场在 2023 年占据最大的市场份额。然而,预计成像细分市场在预测期内的复合年增长率最高。
        • 根据技术,遗传性癌症检测市场分为测序、PCR 和微阵列。测序细分市场在 2023 年占据最大的市场份额,预计该细分市场在预测期内的复合年增长率最高。
        • 根据最终用户,遗传性癌症检测市场分为诊断中心、医院和诊所。 2023 年,医院细分市场占据最大的市场份额。此外,预计同一细分市场在预测期内的复合年增长率最高。

         

        按地域划分的遗传性癌症检测市场份额分析

        遗传性癌症检测市场报告的地理范围主要分为五个地区:北美、亚太地区、欧洲、中东和非洲、南美洲/中南美洲。  

        北美遗传性癌症检测市场分为美国、加拿大和墨西哥。到2023年,美国将占据北美遗传性癌症检测市场的最大份额。北美遗传性癌症检测市场的预计增长是由癌症患者数量增加、政府资助增加以及遗传病发病率上升推动的。近年来美国和加拿大的人口。政府还采取举措提高民众对癌症的认识。例如,美国临床肿瘤学会 (ASCO) 开设了一门关于癌症认识的课程,以传播有关这种疾病的完整和基本知识,包括遗传性癌症遗传学。

         

        遗传性癌症检测市场报告范围

        报告属性细节
        2021年市场规模50.5亿美元
        2031 年市场规模145.9亿美元
        全球复合年增长率(2023 - 2031)11.3%
        历史数据2021-2022
        预测期2023-2031
        涵盖的细分市场按诊断类型
        • 活检
        • 影像学
        按技术
        • 测序
        • 聚合酶链式反应
        • 微阵列
        按最终用户
        • 医院
        • 诊所
        • 诊断中心
        覆盖地区和国家北美
        • 我们
        • 加拿大
        • 墨西哥
        欧洲
        • 英国
        • 德国
        • 法国
        • 俄罗斯
        • 意大利
        • 欧洲其他地区
        亚太
        • 中国
        • 印度
        • 日本
        • 澳大利亚
        • 亚太其他地区
        南美洲和中美洲
        • 巴西
        • 阿根廷
        • 南美洲和中美洲其他地区
        中东和非洲
        • 南非
        • 沙特阿拉伯
        • 阿联酋
        • 中东和非洲其他地区
        市场领导者和主要公司简介
        • 豪洛捷公司
        • 皇家飞利浦公司
        • 奎斯特诊断公司
        • 无数遗传学公司
        • 癌症遗传学公司
        • 英维泰公司
        • 肌原
        • 斯特兰德生命科学列兵。有限公司
        • Pathway Genomics 公司
        • 森托金公司
        • 示例 PDF 通过定性和定量分析展示了内容结构和信息的性质。

         

         

        遗传性癌症检测市场新闻和最新发展

        遗传性癌症检测市场是通过收集初级和二级研究的定性和定量数据来评估的,其中包括重要的公司出版物、协会数据和数据库。以下是遗传性癌症检测市场的进展列表:

        • Exact Sciences Corp. 宣布在美国推出 Riskguard 遗传性癌症测试。该测试使用简单的血液或唾液样本提供针对 10 种常见癌症(包括结直肠癌、子宫内膜癌、胃癌、胰腺癌、乳腺癌、前列腺癌、皮肤癌、卵巢癌、肾癌和内分泌癌)的个体化患者报告,其中包括基因特异性和家族风险。 (Exact Sciences Corp /新闻稿,2024 年 2 月)
        • Devyser宣布推出两款新产品Devyser LynchFAP和Devyser BRCA PALB2。这些试剂盒可对与癌症风险增加相关的基因进行高效、有针对性且可信的分析。 Devyser LynchFAP 提供了一个全面的解决方案来分析 PMS2 和其他 9 个与遗传性结直肠癌综合征相关的基因(来源:Devyser,新闻稿,2023 年 6 月)

         

        遗传性癌症检测市场报告范围和交付成果

        《遗传性癌症检测市场规模和预测(2021-2031)》报告对涵盖以下领域的市场进行了详细分析:

        • 范围内涵盖的所有关键细分市场的全球、区域和国家层面的市场规模和预测
        • 市场动态,例如驱动因素、限制因素和关键机遇
        • 未来主要趋势
        • 详细的 PEST/波特五力分析和 SWOT 分析
        • 全球和区域市场分析,涵盖主要市场趋势、主要参与者、法规和最新市场发展
        • 行业格局和竞争分析,涵盖市场集中度、热图分析、知名参与者和最新发展
        • 详细的公司简介

        Hereditary Cancer Testing Market Report Scope

        Report Attribute Details
        Market size in US$ 5.05 Billion
        Market Size by US$ 14.59 Billion
        Global CAGR 11.3%
        Historical Data 2021-2022
        Forecast period 2023-2031
        Segments Covered By 诊断类型(活检、影像学)
        By 技术(测序、PCR、微阵列)
        By 最终用户(医院、诊所、诊断中心)
        Regions and Countries Covered 北美(美国、加拿大、墨西哥)
        • 北美(美国、加拿大、墨西哥)
        欧洲(英国、德国、法国、俄罗斯、意大利、欧洲其他地区)
        • 欧洲(英国、德国、法国、俄罗斯、意大利、欧洲其他地区)
        亚太地区(中国、印度、日本、澳大利亚、亚太地区其他地区)
        • 亚太地区(中国、印度、日本、澳大利亚、亚太地区其他地区)
        南美洲和中美洲(巴西、阿根廷、南美洲和中美洲其他地区)
        • 南美洲和中美洲(巴西、阿根廷、南美洲和中美洲其他地区)
        中东和非洲(南非、沙特阿拉伯、阿联酋、中东和非洲其他地区)
        • 中东和非洲(南非、沙特阿拉伯、阿联酋、中东和非洲其他地区)
        Market leaders and key company profiles
      • Hologic Inc.
      • Koninklijke Philips N.V.
      • Quest Diagnostics Incorporated
      • Myriad Genetics, Inc.
      • Cancer Genetics Inc.
      • Invitae Corporation
      • Myogenes
      • Strand Life Sciences Pvt. Ltd.
      • Pathway Genomics Corporation
      • CENTOGENE AG
      • Report Coverage
        Report Coverage

        Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends

        Segment Covered
        Segment Covered

        This text is related
        to segments covered.

        Regional Scope
        Regional Scope

        North America, Europe, Asia Pacific, Middle East & Africa, South & Central America

        Country Scope
        Country Scope

        This text is related
        to country scope.

        The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.

        1. Data Collection and Secondary Research:

        As a market research and consulting firm operating from a decade, we have published and advised several client across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.

        Several associations trade associates, technical forums, institutes, societies and organization are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in last 3 years are scrutinized and analyzed to understand the current market trends.

        1. Primary Research:

        The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.

        For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.

        A typical research interview fulfils the following functions:

        • Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
        • Validates and strengthens in-house secondary research findings
        • Develops the analysis team’s expertise and market understanding

        Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:

        • Industry participants: VPs, business development managers, market intelligence managers and national sales managers
        • Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.

        Below is the breakup of our primary respondents by company, designation, and region:

        Research Methodology

        Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.

        1. Data Analysis:

        Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.

        • Macro-Economic Factor Analysis:

        We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.

        • Country Level Data:

        Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.

        • Company Profile:

        The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.

        • Developing Base Number:

        Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.

        1. Data Triangulation and Final Review:

        The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.

        We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.

        We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.

        Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

        Related Reports